A snack company that happens to sell soda
Most people think of PepsiCo as the other cola. That framing is not merely incomplete — it points at the wrong half of the company. The single most useful fact about PepsiCo is this: the snacks earn roughly six times the margin of the drinks.
In 2025, Frito-Lay North America — Lay's, Doritos, Cheetos, Tostitos, Ruffles — generated $6.17 billion of operating profit at a 22.4% margin. PepsiCo Beverages North America, the business everybody associates with the name, earned an operating margin of 3.86%. Frito-Lay is roughly a quarter of group revenue and something close to half of divisional operating profit. When we analysed Coca-Cola we called it one of the great franchises on Earth and gave it a 10 for moat. The uncomfortable truth this report has to deal with is that PepsiCo's best business is not the one that competes with Coca-Cola at all.
And the reason the stock sits near a 52-week low, on a dividend yield of 4.12% that is historically high for this company, is that both halves are under pressure at once. Beverage margins in its home market have collapsed from 9.35% to 3.86% in two years. Frito-Lay's margin has slipped from 25.9% to 22.4%. Earnings per share fell from $6.95 to $6.00 last year. And underneath all of it sits the question our reader asked us to answer properly: after more than fifty consecutive years of dividend increases, is the dividend still safe?
PepsiCo cut prices by up to 15% on Lay's, Doritos, Cheetos and Tostitos — and volumes still came in flat. That single fact tells you more about pricing power than any margin table.
This is the third analysis on our board to run into GLP-1 weight-loss drugs. We made them the central risk in our McDonald's report, and analysed both Novo Nordisk and Eli Lilly, the companies making them. PepsiCo is where that thread lands hardest, because snacking between meals is precisely the behaviour these drugs suppress. The question we could not answer at McDonald's — whether the effect is measurable or merely narrative — has an answer here, and it is measurable.
| Founded | 1898 as Brad's Drink · bankrupt twice (1923, 1931) · ★ merged with Frito-Lay in 1965 — the event that made the company |
| Sector / Industry | Consumer Defensive · Snacks & beverages — the twin study to Coca-Cola |
| CEO | Ramon Laguarta (since 2018) · ⚠️ under activist pressure since September 2025 |
| ★ Corporate detail | A NORTH CAROLINA corporation (reincorporated 1986) — not Delaware. Relevant to governance and litigation venue. |
| Revenue (FY2025) | $93.9B (+2.2%) · operating margin 14.4% · net income $8.24B · EPS $6.00 (down from $6.95) |
| Market capitalisation | ~$190.6B · dividend $5.92/yr annualised · yield ~4.2% · total debt $49.9B |
Two bankruptcies, a nickel jingle, and the merger that mattered
| Year | Milestone |
|---|---|
| 1898–1931 | Founded as Brad's Drink, renamed Pepsi-Cola in 1902 — and went bankrupt TWICE, in 1923 and again in 1931. This company began life as a failure, twice over, and was rescued by Loft Inc., a candy chain that wanted a cheaper cola for its soda fountains. |
| 1930s | The Depression-era masterstroke: twelve ounces for a nickel while Coca-Cola sold six. A radio jingle carried it into American homes and Pepsi took real share from Coke for the first time — the origin of a permanent value positioning it has never entirely escaped. |
| 1965 | ★ THE DEFINING EVENT: Pepsi-Cola merges with Frito-Lay to create PepsiCo. Everything that makes this company interesting today — the margins, the moat, the reason it is not merely 'the other cola' — traces to this merger rather than to the drink it is named after. |
| 1975 | The Pepsi Challenge: blind taste tests showing consumers preferred Pepsi. It worked so well it helped provoke Coca-Cola's catastrophic 1985 'New Coke' reformulation — arguably PepsiCo's greatest marketing victory, and one it could not convert into lasting share. |
| 1997–2001 | Portfolio reshaping: spins off its restaurants (KFC, Pizza Hut, Taco Bell) as Tricon/Yum! Brands, then buys Tropicana (1998) and Quaker Oats with Gatorade (2001). Gatorade in particular remains one of its strongest assets. |
| 2023–24 | The Quaker recall: Salmonella at the Danville, Illinois plant. The FDA's warning letter found the same strain had likely been resident since 2020. PepsiCo resolved it by permanently closing the plant — 510 jobs, then demolition (Part X). |
| Sept 2025 | Elliott Management discloses a ~$4 billion stake and demands change. In December PepsiCo agreed to a programme including a 20% SKU cut and price reductions on core snacks — without giving Elliott a single board seat. |
The 1965 merger is the fact to carry forward. PepsiCo has spent sixty years being measured against Coca-Cola in a contest it has never won and does not need to win, while quietly building something Coca-Cola does not have at all: a dominant position in salty snacks, a category with better economics than carbonated drinks and a distribution moat that is genuinely hard to replicate. That is the subject of Part IV, and it is the reason this is a quality franchise despite everything in Part VII.
As understandable as business gets
It is not the brands — it is the delivery trucks
Ask most investors what protects PepsiCo and they will say the brands. The brands matter, but they are not the durable advantage. The moat is Direct Store Delivery.
Most packaged food reaches a supermarket through the retailer's own warehouse: the manufacturer ships pallets, the retailer decides what goes where, and the product sits on whatever shelf it is given. Frito-Lay does not work that way. Its own employees drive its own trucks to hundreds of thousands of individual outlets — supermarkets, petrol stations, corner shops — and stock the shelves themselves, several times a week. They control the facings, the placement, the freshness, and crucially the end-of-aisle displays where impulse purchases happen.
Why that is so hard to attack. A rival cannot buy this; it must be built store by store over decades, and it only pays for itself at enormous scale — the truck has to be full. It is why Frito-Lay holds a commanding share of American salty snacks, why its margin is 22.4% while the drinks business earns 3.86%, and why private-label competitors, who have no such system, struggle to hold shelf position even when they undercut on price. It is one of the few genuine physical moats left in consumer goods, and it is why we score the moat an 8.
Now the honest part. A distribution moat protects your access to the shelf. It does not protect you when fewer people want what is on it. And it has a second vulnerability that is becoming visible: DSD is a fixed-cost system. Those trucks and drivers cost the same whether volumes rise or fall — which is precisely why five consecutive quarters of falling snack volumes have compressed Frito-Lay's margin from 25.9% to 22.4%. The moat is real, and it is currently operating with less product flowing through it than it was built for. That is also why Elliott's supply-chain review, reporting late this year, matters more than it might sound.
The snacks are carrying the drinks
Put the two North American numbers side by side — 22.4% and 3.86% — and the investment case reorganises itself. The conventional comparison of PepsiCo to Coca-Cola is close to meaningless, because the businesses are not alike. Coca-Cola is a pure, asset-light, ~30%-margin beverage franchise that sells concentrate and lets bottlers carry the capital. PepsiCo owns its own bottling and its own delivery fleet — far more capital-intensive — and its drinks business now earns a margin that would embarrass a supermarket.
Which raises the question Elliott is effectively asking: why are these two businesses in the same company at all? A 22%-margin snack franchise with a distribution moat and a 4%-margin capital-heavy bottling operation have almost nothing in common except a delivery network and a name. We are not predicting a break-up — PepsiCo has not proposed one and Elliott did not extract one — but any reader wondering why an activist showed up with four billion dollars now has the answer in two numbers.
At McDonald's we could not tell. Here we can.
When we wrote about McDonald's we identified GLP-1 drugs as the single ruby risk and admitted we could not yet separate the fear from the effect. PepsiCo is where the evidence exists, because snacking between meals is the exact behaviour appetite suppressants target. The honest answer is that this one is real, and it is in the numbers.
| The evidence it is real | The evidence it is survivable |
|---|---|
| Five consecutive quarters of declining savoury snack volumes. Not one bad quarter — a trend | The category is not collapsing. Consultants studying it call GLP-1 a disruptive trend rather than an existential threat, and international markets are far less affected |
| ★ PepsiCo cut prices by up to 15% on Lay's, Doritos, Cheetos and Tostitos — and volume came in FLAT. When a 15% price cut does not buy volume, the problem is not price | PepsiCo is adapting the product — moving Lay's single-serve packs to 200-calorie portions, pushing protein and hummus lines, reformulating toward fibre and whole grains |
| Snack and confectionery categories are reported down ~12.4% in high-adoption areas ⚠️ (third-party estimate) — a geographic dose-response, which is what a real effect looks like | Frito-Lay still earns 22.4%. Even after the erosion, this remains one of the best margins in packaged food, on a moat rivals cannot copy |
| Capacity is being taken out — plant and distribution-centre closures through 2026 alongside peers doing the same. Companies do not close plants over a narrative | Some of the weakness is not GLP-1 at all — years of aggressive price increases exhausted the low-income US consumer, and private label gained. Those are cyclical, not structural |
Our read: the effect is genuine but the diagnosis is muddled, and that distinction matters for what you pay. Three forces are pressing on the same line item and the market is attributing all of it to the most frightening one. Years of double-digit price increases from 2021 to 2024 stretched the American consumer until elasticity finally bit; private label took share while PepsiCo held the price umbrella; and GLP-1 drugs arrived on top of both. If the volume decline were purely GLP-1, the price cuts would have done nothing — which is roughly what happened. If it were purely price, the cuts should have worked — which they did not. The most likely truth is that PepsiCo overpriced its way into a weaker consumer, and then the drugs arrived to make the recovery harder.
That reading is neither reassuring nor catastrophic, and it points at the same place the numbers do: PepsiCo's earnings power is lower than it was, and the path back runs through cost and mix rather than price. Which is exactly the programme Elliott extracted — and exactly why the dividend arithmetic in the next part has become the central issue.
Revenue up, everything else down
| Metric | Value | Read |
|---|---|---|
| Revenue (FY2025) | $93.9B (+2.2%) | ◆ growing, but on price not volume |
| Operating margin | 14.4% (was 15.6% in 2016) | ▼ eroded over the decade |
| EPS | $6.00 (was $6.95 in 2024) | ▼ DOWN 14% in one year |
| Net income | $8.24B (was $9.58B) | ▼ down $1.3bn |
| ★ Free cash flow | $7.67B | ◆ FLAT at $7–8bn for six years |
| Return on invested capital | 13.2% | ▲ still a good business (ROE 50% flatters — thin equity) |
| Total debt | $49.9B (was $44.6B in 2020) | ▼ RISING while the dividend grew |
| Net debt / EBITDA | 2.31× | ◆ manageable but no longer conservative |
| Shares outstanding | 1,452M → 1,373M | ◆ −5.4% over a decade — a modest buyback |
| Altman-Z / Piotroski | 3.46 / 6 | ▲ no solvency concern |
One line in this table is doing all the damage: free cash flow has been flat at $7–8 billion for six years. Revenue over the same period grew from $70.4 billion to $93.9 billion — a third larger — and none of it reached the cash line. Some of that is capital expenditure running above $4 billion a year; some is working capital; and some is simply that the margin has eroded. But the consequence is arithmetic and inescapable, and it is the subject of the next part.
One presentational warning before you compare PepsiCo to anything. The company's reported earnings and its "core" earnings have diverged sharply — 2025 accounting earnings per share came in at $6.00 while the figure analysts model for that year sat above $8. The gap is impairments and restructuring charges. Neither number is dishonest, but a great deal of commentary quotes the higher one and the resulting price-to-earnings multiple looks considerably cheaper than the accounts support. Where the two disagree, we have used the accounting number.
The question this report exists to answer
PepsiCo has raised its dividend every year since 1973 — more than five decades, through every recession in living memory. It is a Dividend King, and that record is not in dispute. The question is not whether the dividend gets paid next quarter. It is whether the arithmetic behind it still works.
The number almost everyone quotes is the payout ratio on earnings: about 74%. That number is close to useless, because dividends are not paid out of earnings — they are paid out of cash. Here is the cash.
| Year | Free cash flow | Dividends paid | ★ Coverage | Buybacks | Left over |
|---|---|---|---|---|---|
| 2020 | $6.37B | $5.51B | 1.16× | $2.00B | −$1.14B |
| 2021 | $6.99B | $5.82B | 1.20× | $0.11B | +$1.07B |
| 2022 | $5.60B | $6.17B | 0.91× | $1.50B | −$2.07B |
| 2023 | $7.92B | $6.68B | 1.19× | $1.00B | +$0.24B |
| 2024 | $7.19B | $7.23B | 0.99× | $1.00B | −$1.04B |
| ★ 2025 | $7.67B | $7.64B | 1.00× | $1.00B | −$0.97B |
Read the two middle columns together. Over six years the dividend grew 39% — from $5.51 billion to $7.64 billion — while free cash flow went nowhere. Coverage has fallen from a comfortable 1.20× to exactly 1.00×. In 2024 it was below one. The dividend now consumes every dollar of cash the business produces after capital spending.
And the company is still buying back $1 billion of stock on top. Look at the final column: in four of the last six years, PepsiCo spent more than it generated. The gap has to come from somewhere, and it has: total debt has risen from $44.6 billion to $49.9 billion over the same period. To be precise about what that means — the dividend itself is funded by operations; the buyback, at the margin, is funded by the balance sheet.
The honest verdict on the dividend, stated plainly: it is safe, and it has stopped being a growth story. An investor buying PepsiCo today for income is buying a well-covered 4.1% yield from a business with fifty years of discipline behind it — that is a perfectly good thing to own, and better than the yield offered by most of this company's history. But an investor buying it expecting the mid-single-digit dividend growth of the past decade to continue is buying something the cash flow statement does not currently support. The dividend is not the risk here. The compounding is.
Compare this to Coca-Cola, which we rated an 8.0 and told readers to accumulate. Coca-Cola's asset-light concentrate model converts a far higher share of revenue into cash, precisely because the bottlers carry the capital. PepsiCo owns its trucks and its bottling plants. That is the structural reason its free cash flow has not kept pace, and it is the clearest argument that — for a pure income investor — Coca-Cola remains the better security even though PepsiCo has the better single business inside it.
Cheap against its own history, fair against its own earnings
| Yardstick | Today | Context | Read |
|---|---|---|---|
| P/E — trailing | 18.3× | on TTM earnings; ~23× on 2025 accounting EPS of $6.00 | fair, not cheap |
| Dividend yield | 4.12% (4.24% on the current rate) | historically high for PepsiCo | the main attraction |
| Price / free cash flow | 20.5× | on flat free cash flow | full for a no-growth cash line |
| EV / EBITDA | 12.5× | vs a decade largely spent above 15× | genuinely below its own history |
| Price vs 52-week range | $139.56 of $133.73–$171.48 | near the low | sentiment already poor |
| DCF fair value | $202.90 | +45.4% — assumes cash flow recovers | generous; the input is the question |
| Analyst consensus | $155.64 (+11.5%) | 1 strong buy / 15 buy / 29 hold / 1 sell | lukewarm — mostly on hold |
PepsiCo is cheaper than it has been in a decade on almost every measure that matters, and the yield of 4.1% is among the highest this company has offered in living memory. Against a Walmart at 40 times earnings and a Costco at 47, a business of this quality at 18 times earnings and 12.5 times enterprise value to EBITDA looks like exactly what our reader asked for — quality on sale.
Three things stop us calling it a bargain. First, the multiple is only genuinely low if you use the "core" earnings that exclude impairments; on the accounting numbers the shares trade closer to 23 times a falling earnings stream. Second, the discounted-cash-flow model's $202 fair value rests entirely on cash flow recovering from six flat years — it is an answer to the question, not evidence for it. Third, and most tellingly, the analysts who follow this company closely see only 11.5% upside and twenty-nine of forty-six sit on hold. That is not a market overlooking a wonderful business; it is a market that has looked and is waiting for evidence.
So the verdict is "The Dividend Is Safe — The Growth Isn't." I score valuation and yield a 7: genuinely attractive for income, not yet compelling for total return. Buy it here if you want a well-covered 4.1% yield from one of the best distribution moats in consumer goods, and expect the payout to grow slowly until the cash flow moves. Set your price toward $125 — where the yield approaches 4.75%, roughly 6% below the 52-week low — if you want to be paid properly for a franchise whose earnings are still falling, whose price cuts have not yet bought volume, and whose turnaround programme does not report until the end of this year.
A resident salmonella strain, a dismissed FTC case, and $4bn of pressure · verified August 2026
Verified the week of publication. The two ruby risks are operational and financial rather than legal: the volume decline (five straight quarters, unrescued by price cuts of up to 15%) and the dividend coverage at 1.00× analysed in Part VIII. On the activist: Elliott Management disclosed a roughly $4 billion stake on 2 September 2025 and PepsiCo announced an agreed programme on 8 December 2025 — a ~20% reduction in US SKUs, ingredient reformulation, price reductions on core snack brands, a North American supply-chain review reporting late 2026, workforce reductions, and margin improvement beginning this year. Notably Elliott received no board seats and there was no proxy fight. ⚠️ We found only a Regulation FD press release, not a signed cooperation agreement on file, so this should be described as an aligned announcement rather than a contract. On litigation, the record is unusually clean for a company this size: no securities class action and no shareholder derivative complaint has been filed — two law firms announced pre-suit investigations in March 2026, but an investor alert is a solicitation, not a lawsuit. (Note that PepsiCo is a North Carolina corporation, so Delaware Chancery is not its venue.) The Quaker recall class action settled for $6.75 million with final approval in August 2025, though six objector appeals remain pending at the Second Circuit. The damaging document is the FDA's June 2024 warning letter, which found thirteen environmental samples positive for the same salmonella strain since 2022 and concluded PepsiCo "likely had a resident strain" possibly surviving since 2020; PepsiCo resolved it by permanently closing and demolishing the Danville plant, and the FDA formally closed the matter in September 2024. The FTC's Robinson-Patman case alleging preferential pricing for Walmart was voluntarily dismissed by the FTC in May 2025 after a change in commission composition, though the complaint was later unsealed and private follow-on suits continue. Four plastic-pollution suits are the only matters PepsiCo discloses in its legal proceedings — the New York Attorney General's case was dismissed and is on appeal; Baltimore's public-nuisance claim survived dismissal with argument expected by September 2026.
You asked me to look at whether PepsiCo's dividend is safe, and I want to answer that first, before anything else, because it is the reason most people own this company. Yes — it is safe. This business has raised its dividend every year since 1973, through every recession any of us can remember, and nothing I found suggests that record is about to end. But I also found something that has not been widely written about, and once you have seen it you cannot unsee it: over the past six years PepsiCo's dividend has grown by thirty-nine percent while the cash it generates has not grown at all. In 2020 the dividend was covered one and a fifth times over by free cash flow. Last year it was covered exactly once. Not once and a bit. Once. Every dollar the company produced after paying for its factories and trucks went straight back out to shareholders — and then it borrowed to buy back a billion dollars of stock on top. In four of the last six years, PepsiCo spent more than it earned, and the difference shows up as five billion dollars of extra debt.
That is not a crisis. I want to be careful here, because there is a kind of writing about dividends that treats every tightening as an imminent cut, and that is not what this is. PepsiCo has a billion dollars of buybacks it can stop tomorrow before it touches the dividend, more than four billion of annual capital spending it can moderate, an investment-grade balance sheet, and a new cost programme just beginning. The dividend is not going anywhere. But the growth of it is a different matter entirely. You cannot raise a payout by five or seven percent a year, forever, against cash flow that has been flat for six years. Something has to give, and what gives first is the size of the annual increase. The four percent yield is real and well earned. The dividend growth that used to come with it is on hold until the cash moves.
Now let me tell you what I think this company actually is, because I do not think most people know. PepsiCo is not the other cola. It is a snack business that also happens to sell soda, and the two halves could hardly be more different. Frito-Lay — Lay's, Doritos, Cheetos, Tostitos — earned an operating margin of twenty-two percent last year and something close to half of the company's entire divisional profit. The drinks business in North America, the one the company is named after, earned three point eight six percent. Read those two numbers again. The part everyone thinks of as PepsiCo now keeps under four cents on the dollar in its home market, while Coca-Cola, which we wrote about in June, earns close to thirty percent globally on an asset-light model where somebody else owns the bottling plants. PepsiCo owns its plants and its trucks. That is precisely why its cash flow has not kept up.
And the snack business, which is the good half, is a better franchise than it gets credit for — because the moat is not the brands. It is the trucks. Frito-Lay's own drivers deliver to hundreds of thousands of shops several times a week and stock the shelves themselves, controlling placement and freshness in a way a rival shipping pallets to a retailer's warehouse simply cannot. You cannot buy that. You build it over decades and it only pays at enormous scale. It is one of the last genuine physical moats in consumer goods. It also has a flaw that is showing right now: those trucks cost the same whether they are full or not, which is why five consecutive quarters of falling snack volumes have pushed Frito-Lay's margin down from nearly twenty-six percent to twenty-two.
Which brings me to the weight-loss drugs. When we wrote about McDonald's I said GLP-1 was the single risk I could not size — whether it was a real effect or a frightening story. Here I can answer it, and the answer is that it is real. Snack categories are reported down around twelve percent in the parts of America where these drugs are most used; PepsiCo has now had five straight quarters of declining savoury snack volume; and companies do not close plants and distribution centres over a narrative. But the single most revealing fact I found is this one: PepsiCo cut prices by up to fifteen percent on Lay's, Doritos, Cheetos and Tostitos — and volumes still came in flat. When a fifteen percent price cut does not buy you a single extra bag of crisps, the problem is no longer price. My honest reading is that three things arrived at once — years of aggressive price rises exhausted the American shopper, private label took share while PepsiCo held its umbrella, and then the drugs turned up to make the recovery harder. That is worse than a cyclical story and better than an existential one.
An activist has come to the same conclusion. Elliott Management turned up in September with four billion dollars and by December had extracted a programme: cut a fifth of the American product range, reformulate toward protein and fibre, reduce prices on the core snack brands, cut the workforce, and review the whole North American supply chain — with the results due at the end of this year. Elliott took no board seats and there was no proxy fight, so this is agreement rather than war. But the presence of a four-billion-dollar investor demanding cost discipline in a fifty-year dividend aristocrat tells you the market's patience with flat cash flow has run out. So does the price: these shares sit near their fifty-two-week low, on the highest yield this company has offered in a very long time.
My verdict is "The Dividend Is Safe — The Growth Isn't." At eighteen times earnings and twelve and a half times operating profits, PepsiCo is the cheapest it has been in a decade, and against a Walmart at forty times or a Costco at forty-seven, a business of this quality at this price is close to what you were looking for when you asked me for quality on sale. If you want a well-covered four percent income from one of the best distribution moats in consumer goods, buy it here and be content. But do not mistake it for a bargain yet. The low multiple depends on using the adjusted earnings rather than the audited ones; the model that says these shares are worth two hundred dollars assumes a cash-flow recovery that has not started; and twenty-nine of the forty-six analysts who follow this company closely are sitting on their hands. If you want to be paid properly for the risk that the volumes keep falling, set your price near a hundred and twenty-five dollars, where the yield reaches nearly four and three-quarter percent. And whichever you choose, hold the right expectation: you are buying an income, not a compounding machine — at least until the day the cash flow starts growing again.